Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FREMANEZUMAB vs FULVESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FREMANEZUMAB vs FULVESTRANT: Safety Overview

Metric FREMANEZUMAB FULVESTRANT
Total FAERS Reports 224 17,675
Deaths Reported 2 3,087
Death Rate 0.9% 17.5%
Hospitalizations 39 4,103
Average Patient Age 47.1 yrs 63.0 yrs
% Female Patients 88.8% 99.0%
FDA Approval Date N/A Apr 25, 2002
Manufacturer Teva Pharmaceuticals USA, Inc. BluePoint Laboratories
Route SUBCUTANEOUS INTRAMUSCULAR
Marketing Status N/A Prescription